| Complete (%) | |||
|---|---|---|---|
| 2016 | 2017 | 2018 | |
| Total number of device records | n = 23,599 | n = 23,628 | n = 22,320 |
| Patient characteristics (Patient level) | |||
| Date of birth | 100% | 99% | 100% |
| ASA classification | 99% | 100% | 93% |
| Smoking | 95% | 75% | |
| Length | 88% | 92% | |
| Weight | 88% | 92% | |
| Body Mass Index | 88% | 92% | |
| Surgery characteristics (Breast level) | |||
| Operation date | 100% | 100% | 100% |
| Hospital | 100% | 100% | 100% |
| Laterality | 100% | 100% | 100% |
| Intervention | 100% | 100% | 100% |
| Indication | 68% | 84% | 99% |
| Timing reconstruction | 72% | 85% | 98% |
| RTx (preop) | 87% | 93% | 97% |
| RTx (postop) | 88% | 97% | |
| Surgery techniques (Breast level) | |||
| Incision site | 92% | 97% | 97% |
| Plane | 84% | 88% | 95% |
| Capsulectomy | 90% | 94% | 96% |
| Mastopexy | 90% | 95% | 97% |
| Autologous flap cover | 90% | 95% | 97% |
| Fat grafting | 90% | 95% | 97% |
| Drains | 91% | 98% | 99% |
| ADM/Mesh use | 92% | 95% | 97% |
| ADM/Mesh manufacturer | 62% | 75% | |
| Antiseptic precautions (Breast level) | |||
| Systemic AB (preop) | 93% | 98% | 99% |
| Systemic AB (postop) | 91% | 97% | 97% |
| Antiseptic rinse of implant | 93% | 98% | 100% |
| Antiseptic rinse type | 99% | 98% | 98% |
| Sleeve/Funnel | 92% | 98% | 100% |
| Nipple guards | 90% | 98% | 100% |
| Glove change | 90% | 98% | 100% |
| Indication for revision (Breast level) | |||
| Change TE for implant | 91% | 94% | |
| Flap problem | 85% | 89% | 96% |
| Skin necrosis | 49% | 85% | 95% |
| Skin scarring | 85% | 89% | 96% |
| Deep wound infection | 85% | 89% | 96% |
| Seroma/Hematoma | 85% | 88% | 95% |
| Capsular contracture | 93% | 94% | |
| Capsular contracture grade | 81% | 85% | 99% |
| Breast cancer | 84% | 88% | 96% |
| BIA-ALCL | 82% | 85% | 96% |
| ASIA | 82% | 85% | 96% |
| Breast pain | 84% | 88% | 95% |
| Asymmetry | 84% | 89% | 95% |
| Dissatisfaction with volume | 49% | 86% | 95% |
| Device rupture/deflation | 88% | 92% | 93% |
| Silicone extravasation | 91% | 94% | |
| Silicone extravasation type | 84% | 89% | 99% |
| Device malposition | 86% | 89% | 95% |
| Device characteristics (Device level, inserted) | |||
| Device type | 100% | 100% | 100% |
| Texture | 93% | 95% | 94% |
| Coating | 97% | 97% | 95% |
| Fill | 94% | 96% | 95% |
| Shape | 96% | 98% | 96% |
| Volume/Weight | 97% | 95% | |
| Max. volume TE | 95% | 94% | |
| Intraoperative volume TE | 74% | 95% | |
| Manufacturer | 99% | 94% | 99% |
| Device characteristics (Device level, explanted) | |||
| Device type | 100% | 100% | 99% |
| Texture | 88% | 93% | |
| Coating | 88% | 94% | |
| Fill | 90% | 94% | |
| Shape | 91% | 93% | |
| Manufacturer | 66% | 69% | 95% |
| Inserted abroad | 100% | 98% | 99% |
Total number of device records represents the total number of inserted and explanted device records.
ASA: American Society of Anesthesiologists, RTx: radiotherapy, Preop: preoperatively, Postop: postoperatively, ADM: Acellular Dermal Matrix, AB: antibiotics, TE: tissue expander, BIA-ALCL: Breast Implant Associated - Anaplastic Large Cell Lymphoma, ASIA: Autoimmune Syndrome Induced by Adjuvants.
For 2015 data: see Annual Report (2015–2017).
From: 5, DATA COMPLETENESS
Dutch Breast Implant Registry Annual Report 2018 is licensed under a Creative Commons Attribution 4.0 International License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.